Bukhalid; Raghida

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bukhalid; Raghida.The latest application filed is for "monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligands".

Company Profile

1.8.13

Bukhalid; Raghida - Melrose MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 10,072,299 - Bukhalid , et al. September 11, 2	2018-09-11
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 9,902,999 - Bukhalid , et al. February 27, 2	2018-02-27
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 9,885,087 - Bukhalid , et al. February 6, 2	2018-02-06
Monoclonal And Oligoclonal Anti-egfr Antibodies For Use In The Treatment Of Tumors Expressing Predominantly High Affinity Egfr Ligands Or Tumors Expressing Predominantly Low Affinity Egfr Ligands App 20170356049 - BUKHALID; Raghida ; et al.	2017-12-14
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20170314079 - BUKHALID; Raghida ; et al.	2017-11-02
Monoclonal And Oligoclonal Anti-egfr Antibodies For Use In The Treatment Of Tumors Expressing Predominantly High Affinity Egfr Ligands Or Tumors Expressing Predominantly Low Affinity Egfr Ligands App 20160083800 - BUKHALID; Raghida ; et al.	2016-03-24
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20160002339 - BUKHALID; Raghida ; et al.	2016-01-07
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 9,226,964 - Bukhalid , et al. January 5, 2	2016-01-05
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20150376284 - BUKHALID; Raghida ; et al.	2015-12-31
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20150368361 - BUKHALID; RAGHIDA ; et al.	2015-12-24
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20150368347 - BUKHALID; Raghida ; et al.	2015-12-24
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20150368346 - BUKHALID; Raghida ; et al.	2015-12-24
Antibodies against epidermal growth factor receptor (EGFR) and uses thereof Grant 9,044,460 - Bukhalid , et al. June 2, 2	2015-06-02
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20140234314 - BUKHALID; Raghida ; et al.	2014-08-21
Monoclonal And Oligoclonal Anti-egfr Antibodies For Use In The Treatment Of Tumors Expressing Predominantly High Affinity Egfr Ligands Or Tumors Expressing Predominantly Low Affinity Egfr Ligands App 20140170668 - BUKHALID; Raghida ; et al.	2014-06-19
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20140127207 - BUKHALID; Raghida ; et al.	2014-05-08
Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies Grant 8,691,231 - Bukhalid , et al. April 8, 2	2014-04-08
Monoclonal And Oligoclonal Anti-egfr Antibodies For Use In The Treatment Of Tumors Expressing Predominantly High Affinity Egfr Ligands Or Tumors Expressing Predominantly Low Affinity Egfr Ligands App 20120308576 - BUKHALID; Raghida ; et al.	2012-12-06
Antibodies Against Epidermal Growth Factor Receptor (egfr) And Uses Thereof App 20110287002 - BUKHALID; Raghida ; et al.	2011-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.